CDC Expects Shortage of New Shingles Vaccines
The Centers for Disease Control andPrevention is warning about a shortage of Shringrix, the newest shingles vaccine recommended for individuals 50 years and older, due to greater-than-expected demand.
Vaccines in the Pipeline
Research is paving the way for new preventive vaccines for many different illnesses.
FDA Chooses Influenza Vaccine Strains for the 2018-19 Seasons
FDA’s Vaccines and Related Biological Products Advisory Committee chose the Northern Hemisphere’s 2018-19 influenza (flu) vaccine strains based on the World Health Organization’s recommendations.
Study Finds Mumps Vaccine Protection Wanes Over Time
A recent meta-analysis of six studies of mumps vaccine effectiveness conducted in the U.S. found protection against mumps lasts an average of 27 years after the last dose of the vaccine.
CDC OKs FluMist for 2018-19 Influenza Season
The Centers for Disease Control and Prevention advisory committee has voted 12-2 to recommend FluMist, the nasal spray version of the influenza vaccine, be used during the 2018-19 influenza (flu) season.
The Consequences of Declining Childhood Vaccination
Parents who choose not to vaccinate their children reduce the community immunity threshold that can result in a return of preventable diseases.
Study Finds Vaccines Don’t Weaken Babies’ Immune Systems
A study examined whether the vaccine schedule was associated with an increased risk of infections not targeted by vaccines and found no statistically significant differences in estimated cumulative vaccine antigen exposure through the first 23 months of life.
WHO Recommends Typhoid Vaccine in Children in Endemic Countries
The World Health Organization is recommending a single dose of the typhoid conjugate vaccine for use in infants and children older than 6 months and a catch-up vaccine in children up to 15 years in countries where the infection is endemic.
Influenza Vaccine Coverage Is Highest Among Workplaces with Vaccination Requirements
An Internet panel survey of healthcare personnel (HCP) showed the overall influenza vaccination coverage estimate among HCP was 78.6 percent in the 2016-17 season, an increase of 15 percentage points since the 2010-11 season, but similar to the 2013-14 through 2015-16 seasons, with the highest coverage among those whose workplace had vaccination requirements.
Higher-Potency Rabies IG Vaccine Receives FDA Approval
Grifols’ HyperRAB (rabies immune globulin [human]) has been approved by the U.S. Food and Drug Administration to treat rabies postexposure prophylaxis.